How to Use this Website
Clinical Trials Now Available
ITOR in the News
- Lab21 and ITOR unveil major leap forward in personalized cancer medicine
- Integration of Cancer Centers of the Carolinas with Greenville Health System
- LAB21 Limited to Support New US Cancer Institute with Molecular Diagnostic and Clinical Trials Services
- ITOR paves way for rapid cancer drug development
Transforming Cancer Care at the Institute for Translational Oncology Research
The Institute for Translational Oncology Research (ITOR) of Greenville Health System (GHS) represents a new model of hope in the war against cancer. With a vision to establish an international destination center that develops and delivers innovative, personalized cancer therapies, ITOR of GHS is transforming cancer research and care on multiple levels. The Institute provides Upstate South Carolina patients with some of the most advanced cancer treatments available anywhere in the world while facilitating pioneering research on life-saving cancer drugs.
The Institute is fully integrated with Greenville Health System and the Cancer Centers of the Carolinas and has extensive collaborative partnerships with the pharmaceutical industry, research universities, private sector companies, government agencies, oncology networks, and other strategic organizations. These collaborative partnerships accelerate cancer research and allow the Institute to achieve continued success and evolution.
As ITOR furthers its aspiration to be one of the country's leaders in the fulfillment of an unprecedented translational oncology research model of the future, its ultimate objectives of winning the war against cancer and saving lives become a reality.